NFE2L2 and Parkinson disease: Given its importance in PD and other neurodegenerative disease, NRF2 is an ideal target candidate for the treatment of neurodegenerative diseases and the targeted discovery of new drugs [185,206], although some cautions should be considered as NRF2 activation has also been linked to the survival of some carcinogenic cells.